A multicenter multinational phase 3 randomized study to evaluate the safety and efficacy of treating colorectal cancer patients with recurrent liver metastases using the Litx system plus chemotherapy as compared to chemotherapy only.

Trial Profile

A multicenter multinational phase 3 randomized study to evaluate the safety and efficacy of treating colorectal cancer patients with recurrent liver metastases using the Litx system plus chemotherapy as compared to chemotherapy only.

Completed
Phase of Trial: Phase III

Latest Information Update: 26 Feb 2017

At a glance

  • Drugs Talaporfin (Primary) ; Fluorouracil; Folinic acid; Irinotecan; Oxaliplatin
  • Indications Colorectal cancer; Liver metastases
  • Focus Therapeutic Use
  • Most Recent Events

    • 08 Jul 2010 Planned end date changed from 1 Dec 2009 to 1 Sep 2012 as reported by ClinicalTrials.gov.
    • 21 May 2010 New source identified and integrated (Clinical Trials Registry - India CTRI2009-091-000295).
    • 13 Apr 2010 Additional trial location (India) identified as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top